What is it about?
Up to these days glioblastoma remains a challenge in neurosurgical patients since there is no curative treatment. The average survival of these patients is 12 to 14 months with the best treatment available. We performed a study to find out weather multiwall carbon-nanotubes (CNTs) induced cytotoxicity in glioblastoma cells. By performing an in vitro and in vivo model of experiment we were able to demonstrate that CNTs by themselves are a potentially safe and effective treatment option for glioblastoma.
Featured Image
Why is it important?
After the finding that we report in our work we can justify the continuity of this line of investigation in order to get closer to a possible new treatment for glioblastoma. More over it is important to understand more of this subject in order to be able to start human trials.
Perspectives
We hope that this article contributes to the current knowledge in nanomedicine and specifically in the area of neurosciences and glioblastoma treatment. A lot of research is being done around the world to understand more about glioblastoma and we hope that this article opens a new window of opportunity.
Samuel Romano
Instituto Nacional de Neurología y Neurocirugía
Read the Original
This page is a summary of: Cytotoxicity induced by carbon nanotubes in experimental malignant glioma, International Journal of Nanomedicine, August 2017, Dove Medical Press,
DOI: 10.2147/ijn.s139004.
You can read the full text:
Contributors
The following have contributed to this page
